Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

close-up image of an eye
Research

Merck KGaA spinout iOnctura touts PI3K inhibitor in eye cancer

In head-to-head comparison of patient tumors, iOnctura’s roginolisib outperformed Gilead’s idelalisib in reducing cancer signaling pathway effectors.
Marissa Russo Oct 14, 2026 1:42pm
Photo of a person celebrating at the top of the mountain while the sun setsrises

Verastem CEO says RAS drug 'set new benchmark' for tricky cancer

Oct 14, 2026 10:27am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
Red stop sign on road

Verdiva axes GLP-1 switching trial over ‘market evolution’

Oct 14, 2026 10:13am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Yellow tape measure with a variety of weight loss medication on blue background

Biomea posts data to pitch oral GLP-1 to potential partners

Oct 14, 2026 9:23am